Article Sidebar
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Bioassay-guided fractionation and <i>in vitro</i> antiplasmodial activity of ethyl acetate fractions from <i>Alectryon serratus</i> (Sapindaceae) leaf
Abstract
Purpose: To investigate the antimalarial activity of active fractions from Alectryon serratus leaves and identify their secondary metabolites.
Methods: Fractionation of ethyl acetate fraction from Alectryon serratus leaves was conducted using column chromatography. Five serial concentrations (10, 1, 0.1, 0.01 and 0.001 µg/mL) of each subfraction were tested in vitro against Plasmodium falciparum 3D7 (chloroquine-sensitive). The active subfractions were separated using preparative TLC. Crude isolates were administrated to P. falciparum culture and incubated for 48 h. The percentages of growth inhibition and IC50 were calculated. Secondary metabolites group of sub-fractions and the crude isolate were determined using TLC, FTIR, and UV-VIS spectrophotometry. Chloroquine was used as a standard drug for antiplasmodial testing.
Results: Four sub-fractions, ETA.4, ETA.8, ETA.9 and ETA.11, exhibited antimalarial activity with IC50 values at 0.035, 0.187, 0.015 and 0.017 µg/mL. Sub-fractions ETA.11 separated using preparative TLC yielded ETA.11.1 and ETA.11.2. Sub-fractions ETA.11.1 and ETA.11.2 showed antimalarial activity with IC50 values at 0.011 and 0.01 µg/mL. The TLC chromatogram of active sub-fractions showed flavonoids and phenolic.
Conclusion: Crude isolates ETA.11.1 and ETA.11.2 contain flavonoid compounds and have potential antiplasmodial activity.
